Employer record no. 17796
Syros Pharmaceuticals, Inc.
US DOL LCA disclosure data, FY2020 to FY2024
Total LCA filings
18
Certified
15
Denied
0
FY2024 filings
4
Filings by fiscal year
Peer rank
#1,568 of 2,686 healthcare employers by filings
The ledger
| Fiscal year | Filed | Certified | Denied | Avg offered wage | Avg prevailing |
|---|---|---|---|---|---|
| FY2020 | 2 | 2 | 0 | $236,192 | $166,671 |
| FY2021 | 6 | 6 | 0 | $147,500 | $125,788 |
| FY2022 | 5 | 5 | 0 | $190,440 | $132,388 |
| FY2023 | 1 | 1 | 0 | $167,403 | $136,427 |
| FY2024 | 4 | 1 | 0 | $308,174 | $173,888 |
What they file for
- svp global regulatory affairs & quality & op excellence$422,2183
- associate director of drug safety$200,0002
- senior manager, financial planning & analysis$167,4032
- clinical scientist$155,0001
- contracts manager$120,8391
- manager, fp&a$120,0001
- manager, gmp quality$125,0001
- principal statistical programmer$165,0001
Where
- cambridge, ma18
Every number on this page is free. Members get an email when this employer files again, a CSV of the full record, and the complete rankings with state and job-title filters.
Watch this employerGet the quarterly H-1B update, free
When DOL publishes new filings we send what changed: the biggest movers and the slimmest wage premiums. No account needed. Members also get alerts for Syros Pharmaceuticals, Inc. and any other employer they watch.
Certification rate 83.3%How these numbers are computed